Lisa Bollinger - 28 May 2024 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Lisa Bollinger
Issuer symbol
APGE
Transactions as of
28 May 2024
Net transactions value
$0
Form type
4
Filing time
30 May 2024, 20:07:52 UTC
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Award $0 +18,550 $0.000000 18,550 28 May 2024 Common Stock 18,550 $47.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 18,550 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date.